高效液相色谱法检测人全血环孢素A浓度

目的 建立RP-HPLC法测定全血中环孢素A(CsA)浓度的方法.方法 全血样品经乙醚单步萃取后,采用SB-C18色谱柱(4.6×150 mm,5 μm)进行分离,流动相为乙腈-甲醇-水-异丙醇(58:18:23:1),流速1.4 ml/min,柱温70℃,检测波长208 nm.结果 CsA在50～1 200 ng/ml范围内线形关系良好,最低检测浓度为15 ng/ml,方法平均回收率96.95%,日内RSD 4.31%～6.75%,日间RSD 5.58%～6.97%.结论 本方法稳定性好,灵敏度高,简便快速,可以满足临床器官移植患者CsA血药浓度监测的需要.     

反相高效液相色谱法测定环孢素血浓度

目的:建立一种反相HPLC法监测人全血中环孢素浓度的方法。方法:采用反相C_(18)色谱柱;柱温:70℃;流动相:乙腈-甲醇-水=160:30:15;流速:0.8ml·min~(-1);检测波长:210nm。结果:在15～1 600ng·ml~(-1)范围内,环孢素与内标的峰高比与环孢素浓度有良好的线性关系(r=0.999 3),最低检测限为5 ng·ml~(-1),高、中、低3种浓度平均相对回收率为96.0%～98.3%;日内RSD为1.2%～3.4%(n=5),日间RSD为3.4%～4.3%(n=5)。结论:该法简单、准确、经济,可用于环孢素的血药浓度监测。     

HPLC法测定63名肾移植患者环孢素的全血浓度

目的建立测定全血中环孢素(CsA)浓度的HPLC方法。方法全血样品1 mL,乙醚提取,正己烷洗涤去干扰后采用Diamomil C_(18)柱(200 mm×4.6 mm,5μm)分离;流动相为乙腈-甲醇-水-异丙醇(58:24:17:1,V/V);流速1.0 mL·min~(=1);柱温65℃;检测波长210 nm;环孢素D为内标。结果CsA全血质量浓度为50～2 500μg·L~(-1)时线性关系良好(r=0.995 1)。方法回收率91.43%～96.48%,萃取回收率75.87%～84.96%,日内RSD<6.65%(n=5)。日间RSD<7.86%(n=5)。结论本方法较简便,准确可靠,可用于CsA药动学研究。     

HPLC法测定氯柳硼酊中氯霉素和水杨酸的含量

目的:建立HPLC法测定氯柳硼酊中氯霉素和水杨酸含量的方法。方法:色谱柱Zorbax ODS-C_(18)(150 mm×4.6 mm,5μm);以甲醇-2%乙酸溶液(48:52v/v)为流动相;流速1.0 ml·min~(-1);检测波长为301 nm,柱温30℃。结果:氯霉素在10～60μg·ml~(-1)范围内,浓度与峰面积线性关系良好(r=0.9995),平均回收率99.5%,RSD=0.7%;水杨酸在10～60μg·ml~(-1)范围内,浓度与峰面积线性关系良好(r=0.9995),平均回收率100.2%,RSD=0.6%。结论:该方法专属性好,操作简便、快速,结果准确,可用于氯柳硼酊制剂的质量控制。     

反相高效液相色谱法测定血浆中盐酸伪麻黄碱浓度

目的:建立反相高效液相色谱法测定人血浆中盐酸伪麻黄碱浓度的方法。方法:采用Dikma C_(18)色谱柱(250 mm×4.6mm,5μm),流动相:乙腈-水(含0.2%三乙胺)=10:90(磷酸调pH 3.3);检测波长:195nm,流速:0.8ml·min~(-1)。结果:盐酸伪麻黄碱浓度在20～800ng·ml~(-1)范围内线性关系良好,最低定量浓度为20ng·ml~(-1),提取回收率在59.65%～72.20%之间,日内和日间RSD分别为1.34%～4.11%和7.92%～9.98%。结论:本法操作简便、快速、准确、重现好,适用于盐酸伪麻黄碱的药动学研究。     

RP-HPLC测定氧氟沙星氢化可的松滴耳液的含量

目的:建立氧氟沙星氢化可的松滴耳液含量测定的方法。方法:采用RP-HPLC法测定滴耳液中氧氟沙星与氢化可的松的含量。色谱柱为Poresphere C_(18)(150 mm×4.6 mm,5μm);流动相为甲醇-0.025 mol·L~(-1)磷酸溶液(用三乙胺调pH至3.0)(55:45);流速0.8 ml·min~(-1);检测波长为240 nm;检测灵敏度为0.16AUFS,进样量20μl。结果:氧氟沙星在30～480μg·ml~(-1)浓度范围内,峰面积与浓度的线性关系良好(r=0.999 9),平均回收率为99.8%;氢化可的松在5～80μg·ml~(-1)浓度范围内,峰面积与浓度的线性关系良好(r=0.999 9),平均回收率为99.9%。结论:本方法快速、简便,精密度好,重复性好,可作为氧氟沙星氢化可的松滴耳液的含量测定方法。     

反相高效液相色谱法测定肾移植术后全血环孢素A浓度

目的建立单步萃取反相高效液相色谱法测定人全血中环孢素A(CsA)浓度。方法患者血样经乙醚单步萃取,环孢素D(CsD)为内标,C18色谱柱,乙腈-水(80:20)为流动相,流速1.0ml/min,柱温70℃,检测波长214nm。结果CsA全血浓度在50～600ng/ml范围内线性关系良好,r=0.9998,最低检测浓度为20ng/ml,平均回收率100.44%,日内和日间RSD均低于5%。结论反相高效液相色谱法简便灵敏、准确可靠、经济,可用于临床人体器官移植术后全血中CsA浓度的监测。     

HPLC法测定阴炎净洗液中苦参碱的含量

目的:建立以HPLC法测定阴炎净洗液中苦参碱的方法。方法:色谱柱为Lichrospher NH_2(250mm×4.6mm,5μm);流动相为乙腈-无水乙醇-3%磷酸(80:10:10);流速为1.2ml·min~(-1);柱温为室温;检测波长为208nm。结果:苦参碱在14～560μg·ml~(-1)浓度范围内与峰面积积分值呈良好线性关系(r=0.999 9),平均回收率为97.0%,RSD=0.7%(n=6)。结论:该方法简便、快速、准确,可用于该制剂的质量控制。     

HPLC法测定人血清中甲氧氯普胺的含量

目的:建立HPLC法测定人血清中甲氧氯普胺的浓度。方法:采用地西泮为内标,血清经碱化后,乙酸乙酯提取。色谱柱为Hypersil ODS C_(18)(250mm×4.0mm,5μm),流动相为含0.03%三乙胺的甲醇-水(75:25),流速1.0ml·min~(-1),紫外276 nm波长检测。结果:甲氧氯普胺血清浓度在3.7～660.0ng·ml~(-1)内具有良好线性关系,定量限为2.0ng·ml~(-1),方法回收率为92.7%～97.9%,日内、日间RSD均<10%。结论:本法简便、准确、灵敏,适用于甲氧氯普胺血药浓度监测和药物动力学研究。     

改良RP-HPLC测定全血中环孢素A的浓度

目的建立一种简便的RP-HPLC法测定全血中环孢素A（CsA）的浓度,为临床合理应用CsA提供依据。方法全血样品1 mL经乙醚提取,正己烷洗涤去干扰后,采用Zorbax SB-C18柱（4.6 mm×150 mm,3.5μm）分离,流动相为乙腈-甲醇-水-异丙醇（60∶10∶29∶1）,流速1.5 mL.min^-1,柱温70℃,检测波长210 nm;环孢素D（CsD）为内标。结果CsA全血浓度在25-1 600 ng.mL^-1内线性关系良好（r=0.999 8）,平均方法回收率99.51%,日内、日间RSD均小于5%,最低检测限5 ng.mL^-1。结论本法简便快速,灵敏度高,重复性好,线性范围广。用于患者全血中CsA浓度监测,效果良好。     

Efficacy of gut lavage,hemodialysis, and hemoperfusion in the therapy of paraquat or diquat intoxication

Clinical and in vitro investigations were carried out to test the efficacy of gut lavage, hemodialysis, and hemoperfusion in the treatment of poisoning with paraquat or diquat. In a patient suffering from diquat intoxication 130 times more diquat was removed by gut lavage 30 h after ingestion than was removed by complete aspiration of the gastric contents.Determination of in vitro clearances for paraquat and diquat by hemodialysis showed that, at serum concentrations of 1–2 ppm, such as are frequently encountered in poisoning in man, toxicologically relevant quantities of herbicide cannot be removed from the body. At a concentration of 20 ppm, on the other hand, hemodialysis proved to be effective, the clearance being 70 ml/min at a blood flow rate of 100 ml/min. The efficacy of hemoperfusion with coated activated charcoal was on the whole better. Especially at concentrations around 1–2 ppm, the clearance values for hemoperfusion were some 5–7 times higher than those for hemodialysis.In a patient suffering from paraquat poisoning, both hemodialysis as well as hemoperfusion were carried out. The in vitro results could be confirmed: At serum concentrations of paraquat less than 1 ppm no clearance could be obtained by hemodialysis while by hemoperfusion with activated charcoal quite high clearance values were measured and the serum level dropped down to zero.

---

Zusammenfassung Klinische Untersuchungen und Laboratoriumsversuche wurden durchgeführt, um die Wirksamkeit von Darmspülung, Hämodialyse und Hämoperfusion bei Paraquat- und Deiquat-Vergiftungen zu prüfen.Bei einem Patienten wurde 30 Std nach Deiquat-Aufnahme durch Darmspülung 130mal mehr Deiquat entfernt als durch vollständige Aspiration des Mageninhaltes. In vitro-Versuche ergaben, daß bei Blutserumkonzentrationen von 1–2 ppm, die bei Vergiftungen oft gemessen werden, durch Hämodialyse keine toxikologisch relevanten Paraquat- oder Deiquat-Mengen entfernt werden können. Dagegen erwies sich die Hämodialyse bei 20 ppm und einer Blutumlaufgeschwindigkeit von 100 ml/min mit einer Clearance von 70 ml/min als wirksam. Die Hämoperfusion mit beschicheter Aktivkohle war in diesen Versuchen aber eindeutig überlegen, denn insbesondere bei Konzentrationen um 1–2 ppm waren die Clearance-Werte 5–7mal höher als bei der Hämodialyse.Die in vitro-Ergebnisse wurden bei einem Patienten mit einer Paraquat-Vergiftung bestätigt: Bei Konzentrationen unter 1 ppm war die Hämodialyse wirkungslos, während durch Hämoperfusion relativ hohe Clearance-Werte erreicht wurden, so daß der Serumspiegel rasch unter die Nachweisgrenze abfiel.

     

In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonism

This study describes a new approach for organophosphorous (OP) antidotal treatment by encapsulating an OP hydrolyzing enzyme, OPA anhydrolase (OPAA), within sterically stabilized liposomes. The recombinant OPAA enzyme was derived from Alteromonas strain JD6. It has broad substrate specificity to a wide range of OP compounds: DFP and the nerve agents, soman and sarin. Liposomes encapsulating OPAA (SL)* were made by mechanical dispersion method. Hydrolysis of DFP by (SL)* was measured by following an increase of fluoride ion concentration using a fluoride ion selective electrode. OPAA entrapped in the carrier liposomes rapidly hydrolyze DFP, with the rate of DFP hydrolysis directly proportional to the amount of (SL)* added to the solution. Liposomal carriers containing no enzyme did not hydrolyze DFP. The reaction was linear and the rate of hydrolysis was first order in the substrate. This enzyme carrier system serves as a biodegradable protective environment for the recombinant OP-metabolizing enzyme, OPAA, resulting in prolongation of enzymatic concentration in the body. These studies suggest that the protection of OP intoxication can be strikingly enhanced by adding OPAA encapsulated within (SL)* to pralidoxime and atropine.     

Aquatic Insects and Trace Metals: Bioavailability,Bioaccumulation, and Toxicity

Abstract

The uptake of metals from food and water sources by insects is thought to be additive. For a given metal, the proportions taken up from water and food will depend both on the bioavailable concentration of the metal associated with each source and the mechanism and rate by which the metal enters the insect. Attempts to correlate insect trace metal concentrations with the trophic level of insects should be made with a knowledge of the feeding relationships of the individual taxa concerned. Pathways for the uptake of essential metals, such as copper and zinc, exist at the cellular level, and other nonessential metals, such as cadmium, also appear to enter via these routes. Within cells, trace metals can be bound to proteins or stored in granules. The internal distribution of metals among body tissues is very heterogeneous, and distribution patterns tend to be both metal and taxon specific. Trace metals associated with insects can be both bound on the surface of their chitinous exoskeleton and incorporated into body tissues. The quantities of trace meals accumulated by an individual reflect the net balance between the rate of metal influx from both dissolved and particulate sources and the rate of metal efflux from the organism. The toxicity of metals has been demonstrated at all levels of biological organization: cell, tissue, individual, population, and community. Much of the literature pertaining to the toxic effects of metals on aquatic insects is based on laboratory observations and, as such, it is difficult to extrapolate the data to insects in nature. The few experimental studies in nature suggest that trace metal contaminants can affect both the distribution and the abundance of aquatic insects. Insects have a largely unexploited potential as biomonitors of metal contamination in nature. A better understanding of the physico-chemical and biological mechanisms mediating trace metal bioavailability and exchange will facilitate the development of general predictive models relating trace metal concentrations in insects to those in their environment. Such models will facilitate the use of insects as contaminant biomonitors.     

Steroidal sapogenin contents in some domestic plants

In order to find out the values of the steroid resources for the future use. the compositions and contents of steroidal sapogenins from 13 domestic plants have been investigated. As a result,Dioscorea nipponica, D. quinqueloba andSmilax china were found to have large amount of diosgenin. And pennogenin inTrillium kamtschaticum andParis verticillata, yuccagenin inAllium fistulosum, hecogenin inAgave americana and neochlorogenin inSolanum nigum were appeared to be major steroidal sapogenins.     

Alzheimer’s disease – current trends in basic and clinical research. Highlights from the 16th ECNP

Advances in the molecular biological knowledge of neuronal nicotinic acetylcholine receptors (nAChRs) have led to a growing interest by the pharmaceutical industry in the development of novel compounds that selectively modulate nAChR function. The ability of (-)-nicotine, an activator of nAChRs, to enhance attentional aspects of cognition in animals and humans, to exert neuroprotective and anxiolytic-like effects, and presumably to mediate the negative correlation between smoking and Alzheimer's (and Parkinson's) Disease, has focused interest on the potential therapeutic utility of modulators of nAChR function for treatment of some of the deficits associated with these progressive, neurodegenerative conditions. Numerous compounds are known which activate nAChRs and which might serve as lead compounds toward the development of such agents. The pharmacologic diversity of neuronal nAChR subtypes suggests the possibility of developing selective compounds which would have more favourable side-effect profiles than existing agents. This broader class of agents, collectively called cholinergic channel modulators (ChCMs), is anticipated to encompass compounds which would have more favourable side-effect profiles than existing agents, which generally exhibit low selectivity. This selectivity may be achieved by preferentially activating some subtypes of nAChRs (i.e., Cholinergic Channel Activators, ChCAs) or inhibiting the function of other subtypes (Cholinergic Channel Inhibitors, ChCIs). An overview of the biology of nAChRs and the rationale for the use of ChCMs for the treatment of dementia related to neurodegenerative diseases are presented, followed by a discussion of lead compounds and compounds under consideration for clinical evaluation.